Also Announces Change of AGM Venue

NAPANEE, ON, May 22, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today announced the Company expects to issue its first quarter 2019 financial and operating results after market close on May 29, 2019.

Notice of Change of AGM Venue

The Company also announces a change to the venue of its annual general and special meeting of shareholders (the "Meeting") to be held at 10:00 a.m. EST on Tuesday, June 4, 2019. The Meeting will now be held at the offices of Bennett Jones LLP, Suite 3400, First Canadian Place, 100 King Street West, Toronto, ON M5X 1A4. Except for the change of venue of the Meeting, the information set out in the notice of meeting and information circular with respect to the Meeting, including the date and time of the Meeting and the resolutions to be considered at the Meeting, remain unchanged. Proxy forms and voting instruction forms stating the address of the prior venue shall remain valid.

Visit our website to sign up for VIVO Cannabis updates: https://www.vivocannabis.com/contact/

About VIVO Cannabis™

VIVO, based in Napanee, Ontario, is recognized for trusted, high-quality products and services. It holds production and sales licences from Health Canada and operates world-class indoor cultivation facilities with proprietary plant-growing technology. VIVO has a collection of premium brands targeting unique customer segments, including Beacon Medical™, Fireside™, Canna Farms™ and Lumina™. In August 2018, VIVO acquired Canna Farms, a premium cannabis company based in Hope, British Columbia. Canna Farms was B.C.'s first Licensed Producer and has several years of craft cultivation experience, as well as a significant customer base and positive cash flow. The Company is significantly expanding its production capacity and pursuing partnership and product development opportunities domestically, as well as in select international markets, including Germany and Australia. VIVO also operates Harvest Medicine, a patient-centric and highly scalable network of specialty medical cannabis clinics as well as a free telemedicine service. VIVO has a healthy balance sheet and is well-positioned to accelerate its growth in Canada and internationally. For more information visit: www.vivocannabis.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE VIVO Cannabis Inc.

For further information: VIVO Investor Relations, Craig MacPhail, +1 416-586-1938, [email protected]; NATIONAL Capital Markets, Michael Bumby, Chief Financial Officer, [email protected], VIVO Cannabis Inc.

Related Links

https://www.vivocannabis.com/

